Chun Xu

Dr. Chun Xu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2018 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
SGShaoqing Gong
Shaoqing Gong
BSBrenda Bin Su
Brenda Bin Su
HTHugo Tovar
Hugo Tovar
CMChunXiang Mao
ChunXiang Mao
VGValeria Gonzalez
Valeria Gonzalez
CXChun Xu
Chun Xu
Hypertension affects 33% of Americans while type 2 diabetes and Alzheimer’s disease (AD) affect 10% of Americans, respectively. Ryanodine receptor 3 gene (RYR3) codes for the RYR which functions to release stored endoplasmic reticulum calcium ions (Ca2+) to increase intracellular Ca2+ concentration. Increasing studies demonstrate that altered levels of intracellular Ca2+ affect cardiac contraction, insulin secretion, and neurodegeneration. In this study, we investigated associations of the RYR3 genetic variants with hypertension, AD, and diabetes. Family data sets were used to explore association of RYR3 polymorphisms with risk and age at onset (AAO) of hypertension, diabetes, and AD. Family-based association tests using generalized estimating equations (FBAT–GEE) showed several unique or shared disease-1 associated variants in the RYR3 gene. Three single nuclear polymorphisms (SNPs; rs2033610, rs2596164, and rs2278317) are significantly associated with risk for hypertension, diabetes, and AD. Two SNPs (rs4780174 and rs7498093) are significantly associated with AAO of the 3 diseases. RYR3 variants are associated with hypertension, diabetes, and AD. Replication of these results of this gene in these 3 complex traits may help to better understand the genetic basis of calcium-signaling gene, RYR3 in association with risk and AAO of these diseases.

22 September 2023 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
KWKesheng Wang
Kesheng Wang
LTLaurie A. Theeke
Laurie A. Theeke
CLChristopher Liao
Christopher Liao
NWNianyang Wang
Nianyang Wang
YLYongke Lu
Yongke Lu
CXChun Xu
Chun Xu

23 December 2021 in Cells
Verified
Journal Article
Open access
PDF file
CXChun Xu
Chun Xu
DGDebra Garcia
Debra Garcia
YLYongke Lu
Yongke Lu
KOKaysie Ozuna
Kaysie Ozuna
Donald AdjerohDonald Adjeroh
Donald Adjeroh
OIOn Behalf Of The Alzheimer’s Disease Neuroimaging Initiative
On Behalf Of The Alzheimer’s Disease Neuroimaging Initiative
Angiotensin-converting enzyme-1 (ACE1) and apolipoproteins (APOs) may play important roles in the development of Alzheimer’s disease (AD) and cardiovascular diseases (CVDs). This study aimed to examine the associations of AD, CVD, and endocrine-metabolic diseases (EMDs) with the levels of ACE1 and 9 APO proteins (ApoAI, ApoAII, ApoAIV, ApoB, ApoCI, ApoCIII, ApoD, ApoE, and ApoH). Non-Hispanic white individuals including 109 patients with AD, 356 mild cognitive impairment (MCI), 373 CVD, 198 EMD and controls were selected from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. Multivariable general linear model (GLM) was used to examine the associations. ApoE ε4 allele was associated with AD, as well as ApoAIV, ApoB and ApoE proteins, but not associated with CVD and EMD. Both AD and CVD were associated with levels of ACE1, ApoB, and ApoH proteins. AD, MCI and EMD were associated with levels of ACE1, ApoAII, and ApoE proteins. This is the first study to report associations of ACE1 and several APO proteins with AD, MCI, CVD and EMD, respectively, including upregulated and downregulated protein levels. In conclusion, as specific or shared biomarkers, the levels of ACE1 and APO proteins are implicated for AD, CVD, EMD and ApoE ε4 allele. Further studies are required for validation to establish reliable biomarkers for these health conditions.

14 October 2023 in Journal of Affective Disorders
Verified
Journal Article
Closed access
CXChun Xu
Chun Xu
SWSilas Wang
Silas Wang
BSBrenda Bin Su
Brenda Bin Su
KOKaysie Ozuna
Kaysie Ozuna
CMChunXiang Mao
ChunXiang Mao
KWKesheng Wang
Kesheng Wang

16 February 2022 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
KWKesheng Wang
Kesheng Wang
YLYongke Lu
Yongke Lu
DMDeana F. Morrow
Deana F. Morrow
DXDanqing Xiao
Danqing Xiao
CXChun Xu
Chun Xu
TIThe Alzheimer’s Disease Neuroimaging Initiative
The Alzheimer’s Disease Neuroimaging Initiative

6 July 2023 in Genes
Verified
Journal Article
Open access
PDF file
CXChun Xu
Chun Xu
VPVictoria Padilla
Victoria Padilla
SLStephanie Lozano
Stephanie Lozano
DGDaniela Gamez
Daniela Gamez
BSBin Su
Bin Su
KWKesheng Wang
Kesheng Wang
Alzheimer’s disease (AD), a main cause of dementia, is commonly seen in aging populations with a strong genetic component. AD is one of the most common neurodegenerative disorders; it is a genetically and clinically heterogeneous disease. Specific demographic factors and genetic variants have been identified in non-Hispanic populations; however, limited studies have observed the Hispanic population. Therefore, we focused on investigating a known gene, APOE, associated with AD-related phenotypes and two psychiatric diseases (depression and anxiety) within the U.S. Hispanic population in our current study. A total of 1382 subjects were studied based on data collected from the Texas Alzheimer’s Research and Care Consortium (TARCC, N = 1320) and the Initial Study of Longevity and Dementia from the Rio Grande Valley (ISLD-RGV, N = 62). Questionnaires regarding demographics, medical history, and blood/saliva samples were collected. We genotyped the APOE gene. The current findings indicated that APOE-ε4 was associated with not only AD (p < 0.0001) but also with anxiety (p < 0.0001) and depression (p = 0.0004). However, APOE-ε3 was associated with depression (p = 0.002) in the Hispanic population. We provide additional evidence in which APOE-ε4 increased the risk for AD in Hispanics. For the first time, APOE alleles show increased risks for anxiety and depression in Hispanics. Further research is warranted to confirm the current findings.